How did a clinical-stage biotech from Nanjing go from obscurity to one of the hottest stocks on the Hong Kong Exchange?

Join Dan Koh and Ryan Huang on this episode of Companies to Watch, as they unpack the incredible rise of TransThera Sciences, its groundbreaking small-molecule drug pipeline, the risks behind its jaw-dropping surge, and what investors need to understand before jumping aboard this biotech rocket.

See omnystudio.com/listener for privacy information.